German drug discovery solutions company Evotec AG (EVTCY.PK, EVOTF.PK) reported that its net income for the first nine months of 2018 surged to 52.3 million euros from 12.7 million euros last year. Earnings per share rose to 0.35 euros from 0.09 euros in the year-ago period.
from RTT - Earnings https://ift.tt/2DF2SP8
via IFTTT
No comments:
Post a Comment